Q-Line Biotec IPO
Q-Line Biotec IPO
Overview
Q-Line Biotec IPO is a book build issue of ₹214.48 crores. The issue is entirely a fresh issue of 0.63 crore shares of ₹214.48 crore. Q-Line Biotec IPO opens for subscription on May 21, 2026 and closes on May 25, 2026. The allotment for the Q-Line Biotec IPO is expected to be finalized on May 26, 2026. Q-Line Biotec IPO will list on the NSE SME with a tentative listing date fixed as May 29, 2026. Q-Line Biotec IPO is set issue price band at ₹326 to ₹343 per share. The lot size for an application is 400 shares. The minimum amount of investment required by an individual investor (retail) is ₹2,74,400 (800 shares) (based on upper price). The minimum lot size for investment in HNI is 3 lots (1,200 shares), amounting to ₹4,11,600. Hem Securities Ltd. is the book running lead manager and Purva Sharegistry (India) Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is Hem Finlease Pvt.Ltd.
Total Shares
62,53,200
Issue Size
₹214 Cr
Price Band
₹326 – ₹343
Lot Size
400 shares
Min. Investment
₹2,74,400
Max. Investment
₹2,74,400
Open Date
21 May, 2026
Close Date
25 May, 2026
Allotment
26 May, 2026
Listing
29 May, 2026
Max. Investment
₹2,74,400
Announced
21 May, 2026
Opening Date
21 May, 2026
Closing Date
25 May, 2026
Basis of Allotment
26 May, 2026
Initiation of Refunds
27 May, 2026
Credit of Shares
27 May, 2026
Listing Date
29 May, 2026
Live GMP
Est. Listing: ₹412
Apply via UPI in 5 minutes
Choose your broker • Zero commission on IPO
About Q-Line Biotec IPO
Incorporated in 2010, Q-Line Biotech Ltd. is engaged in the business of developing, manufacturing and marketing a diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, and distribution/supply of diagnostic equipment for different diagnostic healthcare needs.
The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs since 2013 directly or through our distributor/s majorly to diagnostic service
Q-Line Biotec IPO Share Price
Issue Breakdown
Shareholding
Dilution: 36.6% increase in shares
Q-Line Biotec IPO Financial Health
Q-Line Biotec IPO Lot Size
Investors can bid for a minimum of 800 shares and in multiples of 400 shares thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 800 | ₹2,74,400 |
| Individual investors (Retail) (Max) | 2 | 800 | ₹2,74,400 |
| S-HNI (Min) | 3 | 1200 | ₹4,11,600 |
| S-HNI (Max) | 7 | 2800 | ₹9,60,400 |
| B-HNI (Min) | 8 | 3200 | ₹10,97,600 |
(All values in CR)
Q-Line Biotec IPO Valuations
| Metric | Value |
|---|---|
| ROE | 16.88 |
| ROCE | 13.32 |
| Debt/Equity | 1.06 |
| RoNW | 16.88 |
| PAT Margin | 16.65 |
| EBITDA Margin | 27.64 |
| - | - |
(All values in CR)
Q-Line Biotec IPO Strength & Risk
Q-Line Biotech IPO – Strength
- Operates in the growing diagnostics and healthcare sector
- Focus on IVD reagents, molecular diagnostics, POCT devices, and pathology equipment
- Strong improvement in profitability and EBITDA margins
- In-house manufacturing and R&D capabilities
- IPO proceeds planned for debt reduction
- Positive grey market premium indicating strong listing sentiment
- Experienced presence in diagnostic products segment
Q-Line Biotech IPO – Risk
- High debt levels remain a concern
- Debt-to-equity ratio is relatively elevated
- CRISIL “Issuer Not Cooperating” remark raises governance concerns
- SME IPOs carry high volatility and low liquidity risk
- Revenue growth is relatively flat despite profit growth
- Profit expansion mainly driven by margins rather than strong sales growth
- Large minimum investment size increases retail risk
- Possibility of sharp price swings after listing
- Long-term visibility and governance quality still need monitoring
Q-Line Biotec IPO GMP
Q-Line Biotec SME IPO last GMP is ₹69, last updated May 19th 2026 08:00 AM. With the price band of 343.00, Q-Line Biotec SME IPO's estimated listing price is ₹412 (cap price + today's GMP).The expected percentage gain/loss per share is 20.12%. >> Q-Line Biotec SME IPO Retail Subject to Sauda: ₹21000 The lowest GMP is ₹0.00, while the highest GMP is ₹69.00.
Last updated 19 May, 2026 · Source: aggregated grey-market dealers
| Date | IPO Price | GMP | Sub2 Sauda | Est. Listing | Est. Profit | Updated |
|---|---|---|---|---|---|---|
| 19 May, 2026 | 343 | ₹69 | - | ₹412 (20.12%) | 27600 | 19 May, 2026 |
| 18 May, 2026 | 343 | ₹69▲ | - | ₹412 (20.12%) | 27600 | 18 May, 2026 |
| 17 May, 2026 | 0 | ₹0 | - | ₹ (%) | - | 17 May, 2026 |
Disclaimer: GMP is an unofficial signal from grey-market dealers and is not regulated by SEBI. Use it alongside subscription data and other research for informed decision-making.
How to Apply for Q-Line Biotec IPO
Login to Your Trading App
Open Zerodha, Upstox, Groww, Angel One, or any brokerage app.
Go to IPO Section
Find Q-Line Biotec IPO under the IPO section. Select it and enter your bid details — choose lot size and price (cut-off price recommended).
Enter UPI ID and Submit
Provide your UPI ID linked to your bank account and submit the application.
Approve Mandate on UPI App
Open your UPI app (Google Pay, PhonePe, Paytm, BHIM) and approve the IPO payment request.
Application Confirmed
Your funds will be blocked in your account until the IPO allotment process is completed.